The project is intended to evaluate the pre-clinical safety and performance of the Hexiris MIGS device through the use of a long-term (6-month) implantation study.
Hexiris Inc.
9 enregistrements totalisant 519,037.58 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $514,963 | 8 enregistrements |
| Affaires mondiales Canada | $4,075 | 1 enregistrement |
Enregistrements
The next generation of implant and delivery system for ab-external minimally invasive glaucoma surgery (MIGS) which will enable bringing glaucoma surgery from the operating room to outpatient clinics.
Presenting early-stage glaucoma patients with a minimally invasive approach to lower intraocular pressure with a bleb-forming procedure as an alternative to traditional trabeculectomy or tube surgery....
Complete prototype validation of innovative MIGS (Minimally Invasive Glaucoma Surgery) devices which will enable bringing glaucoma surgery from the operating room to outpatient clinics. By the end of...
The firm is advancing development of their prototyped device for minimally invasive glaucoma surgery. This game changer device will make the treatment of glaucoma safer, more accessible and cost-effe...
The Project will support development of intellectual property capacity within the Firm.
The Project will support development of intellectual property capacity within the Firm
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research...